2017.12.19 CYBERDYNE obtained marketing clearance from U.S. FDA for Medical HAL as a medical device.

2017.11.24 Kawasaki City and Munich Biocluster Management Organizations (BioM) sign memorandum of understanding on promoting business exchanges centered on health, medicine, and welfare.

2017.11.02 9 Doctors in Southeast Acquired Minimally Invasive Surgery. Doctors learned VATS and Small-Thoractomy Techniques at Johnson & Johnson.

2017.08.04 Medtronic Innovation Center Japan to be opened at Kawasaki KINGSKYFRONT on 1 September 2017

2017.08.03 Tokyo Institute of Technology and Kawasaki City are Combining Forces in R&D on Computational Drug Discovery for Middle Molecules at Kawasaki KING SKYFRONT

2017.08.01 Notice of Orphan Drug Designation of NC-6004 (biliary tract cancer) by the U.S. FDA

2017.02.21 CYBERDYNE won the Prime Minister’s Award in the third Nippon Venture Awards

2017.02.08 Kazunori Kataoka is elected a foreign member of the National Academy of Engineering (USA), “For pioneering contributions to the design of supramolecular nanostructures and their application to drug and gene delivery systems.”

2017.01.26 Kawasaki's life science research district sale completed: JSR Corporation and Kawasumi Laboratories Inc., succeed in winning the bid